EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2026-01-14 · 9999999995-26-000173
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2026-01-13 · 0001185185-26-000117
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-1 and confirms the priced prospectus.
2026-01-12 · 0001185185-26-000110
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows S-1/A in the pre-IPO sequence.
2025-12-31 · 0001185185-25-002208
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior 424B4 filing.
2025-12-05 · 0001185185-25-001944
424B4
priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Price $4.00 · 15,278,771 shares · Gross proceeds $0.00
Common Stock · Exchange OTC_PINK · Ticker MITI · Selling stockholders only · Use of proceeds selling stockholders with no issuer proceeds
2025-05-15 · 0001185185-25-000486
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2025-05-14 · 0001185185-25-000439
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2025-05-14 · 9999999995-25-001600
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2025-05-08 · 0001185185-25-000406
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows RW in the pre-IPO sequence.
2025-04-18 · 0001185185-25-000314
RW
withdrawn
Withdrawal request
Issuer requested withdrawal of the registration statement.
Follows S-1/A and ends the active registration process.
2023-08-29 · 0001185185-23-000925
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2,022 shares
Series A Warrant to Purchase One Share · Exchange Nasdaq Capital Market · Ticker MITI · Each Unit consists of one share of Common Stock, one Series A Warrant, and one Series B Warrant · Series A Warrant exercisable at $X per share, expiring 5 years; Series B Warrant exercisable at $X per share, expiring 15 months · Use of proceeds For general corporate purposes · Flags units, warrants · Underwriters Maxim Group LLC
2022-10-20 · 0001185185-22-001189
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2022-10-03 · 0001185185-22-001143
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2,022 shares
Common Stock · Exchange OTCQB · Ticker MITI · Each Unit consists of one share of Common Stock and two Warrants · Each Unit Warrant is exercisable for one share of Common Stock · Flags units, warrants · Underwriters Maxim Group LLC
2022-09-12 · 0001185185-22-001085
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2022-08-03 · 0001185185-22-000883
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2022-06-30 · 0001185185-22-000796
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2022-04-26 · 0001185185-22-000506
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2022-02-10 · 0001185185-22-000159
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
Mitesco, Inc. is conducting an initial public offering (IPO) of its common stock, aiming to expand its network of primary care clinics focused on wellness and technology-driven care. The company plans to open additional clinics in Minnesota and Colorado, leveraging nurse practitioners and integrated health approaches. The offering includes shares for the company and selling stockholders, with proceeds intended for clinic expansion and operational needs. The filing also notes the company's application for Nasdaq listing, contingent on approval.
2021-11-26 · 0001185185-21-001758
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Mitesco, Inc. is registering 25,663,320 shares of common stock for resale by selling stockholders, including shares from Series C Preferred Stock conversion, Warrants, and compensation to the placement agent. The company will not receive proceeds from the sale but may benefit from warrant exercises. The filing outlines the company's focus on primary care clinics using nurse practitioners and telemedicine, with plans for expansion in Minnesota and Colorado.
2021-05-04 · 0001185185-21-000603
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1 and marks the registration effective.
Mitesco, Inc. filed a Notice of Effectiveness for its S-1 registration statement, effective May 3, 2021. The filing relates to the resale of up to 25,663,320 shares of common stock by selling stockholders, including shares from convertible preferred stock conversions, warrant exercises, and placement agent compensation. The company does not receive proceeds from the resale but may benefit if warrants are exercised. The stock is traded on the OTCQB under 'MITI'.
2021-05-03 · 9999999995-21-001769
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
Mitesco, Inc. is registering up to 25,663,320 shares of common stock for resale by selling stockholders, including shares from Series C Convertible Preferred Stock conversion, Series A and B Warrant exercises, and shares issued to the Placement Agent. The company will not receive proceeds from the sale but may benefit if warrants are exercised. The shares are traded on OTCQB under 'MITI'.
2021-04-27 · 0001185185-21-000573
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
17,872,940 shares
Common Stock · Exchange OTCQB · Ticker TNTY · Selling stockholders only · Use of proceeds resale of shares by selling stockholders
This prospectus supplement updates the registration statement for Trunity Holdings, Inc. (TNTY) to include information from recent 8-K filings. It highlights the appointment of Dr. Ivan Berkowitz to the board of directors and a stock option agreement with CEO Arol Buntzman. The filing incorporates financial results from the 10-Q for the period ended September 30, 2013, and emphasizes risks associated with the company's financial condition and market position.
2014-01-24 · 0001575705-14-000011
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The prospectus supplement updates the final prospectus with Q3 2013 financial data from the 10-Q filing, including condensed consolidated financial statements and management's discussion and analysis. It outlines the resale of up to 17,872,940 shares of common stock by selling stockholders, with the company's stock listed on the OTCQB under 'TNTY'. The supplement incorporates the quarterly report's financial results and disclosures.
2013-11-26 · 0001575705-13-000017
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
17,872,940 shares
Common · Exchange OTCQB · Ticker TNTY · Warrants to purchase shares at $1.00 per share · Selling stockholders only · Use of proceeds Selling stockholders will receive all proceeds
The 424B3 filing relates to the resale of up to 17,872,940 shares of common stock and warrants by selling stockholders of Trunity Holdings, Inc. The company will not receive proceeds from the resale but will bear certain registration costs. The shares are listed on the OTCQB Market, and the offering includes shares held by entities and individuals with specified ownership percentages. The plan of distribution outlines various methods for selling shares, including over-the-counter transactions and private sales.
2013-11-05 · 0001575705-13-000011
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1 and marks the registration effective.
The filing represents the effectiveness of Trunity Holdings, Inc.'s S-1 registration statement, allowing the resale of 17,872,940 shares of common stock by existing stockholders. The company itself is not issuing new shares or receiving proceeds, with all net proceeds going to the selling stockholders. The shares are listed on the OTCQB market, and the offering includes shares issuable upon warrant exercises. The prospectus highlights risks related to market volatility, lack of liquidity, and the company's financial position.
2013-09-30 · 9999999995-13-002877
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
First tracked pre-IPO filing for this issuer.
Trunity Holdings, Inc. is registering 17,872,940 shares of common stock (including 8,936,470 shares issuable upon warrant exercise) for resale by selling stockholders. The company is not receiving proceeds from the offering, which is being conducted on a self-underwritten basis. The shares are listed on the OTCQB market, and the offering includes potential sales by multiple institutional and individual shareholders. The prospectus highlights risks related to the speculative nature of the stock, lack of company proceeds, and potential market impact from large-scale sales.
2013-09-09 · 0001575705-13-000005